These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 32308025
1. The Role of LncRNA H19 in MAPK Signaling Pathway Implicated in the Progression of Bronchopulmonary Dysplasia. Mo W, Li Y, Chang W, Luo Y, Mai B, Zhou J. Cell Transplant; 2020; 29():963689720918294. PubMed ID: 32308025 [Abstract] [Full Text] [Related]
2. Differential expression of long non-coding RNAs in hyperoxia-induced bronchopulmonary dysplasia. Bao TP, Wu R, Cheng HP, Cui XW, Tian ZF. Cell Biochem Funct; 2016 Jul; 34(5):299-309. PubMed ID: 27137150 [Abstract] [Full Text] [Related]
3. Mechanism of lncRNA H19 in Regulating Pulmonary Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia Newborn Mice. Zhang L, Wang P, Shen Y, Huang T, Hu X, Yu W. Am J Perinatol; 2022 Jul; 39(10):1089-1096. PubMed ID: 33285606 [Abstract] [Full Text] [Related]
4. Long non-coding RNA MALAT1 protects preterm infants with bronchopulmonary dysplasia by inhibiting cell apoptosis. Cai C, Qiu J, Qiu G, Chen Y, Song Z, Li J, Gong X. BMC Pulm Med; 2017 Dec 13; 17(1):199. PubMed ID: 29237426 [Abstract] [Full Text] [Related]
5. Changing expression profiles of mRNA, lncRNA, circRNA, and miRNA in lung tissue reveal the pathophysiological of bronchopulmonary dysplasia (BPD) in mouse model. Wang J, Yin J, Wang X, Liu H, Hu Y, Yan X, Zhuang B, Yu Z, Han S. J Cell Biochem; 2019 Jun 13; 120(6):9369-9380. PubMed ID: 30802330 [Abstract] [Full Text] [Related]
6. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Pan JX. Eur Rev Med Pharmacol Sci; 2017 Jan 13; 21(2):322-328. PubMed ID: 28165553 [Abstract] [Full Text] [Related]
7. In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration. Geng H, Bu HF, Liu F, Wu L, Pfeifer K, Chou PM, Wang X, Sun J, Lu L, Pandey A, Bartolomei MS, De Plaen IG, Wang P, Yu J, Qian J, Tan XD. Gastroenterology; 2018 Jul 13; 155(1):144-155. PubMed ID: 29621481 [Abstract] [Full Text] [Related]
8. LncRNA CASC2 targets CAV1 by competitively binding with microRNA-194-5p to inhibit neonatal lung injury. Ji L, Liu Z, Dong C, Wu D, Yang S, Wu L. Exp Mol Pathol; 2021 Feb 13; 118():104575. PubMed ID: 33212124 [Abstract] [Full Text] [Related]
9. Tie-2 Cre-Mediated Deficiency of Extracellular Signal-Regulated Kinase 2 Potentiates Experimental Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonatal Mice. Menon RT, Shrestha AK, Barrios R, Reynolds C, Shivanna B. Int J Mol Sci; 2020 Mar 31; 21(7):. PubMed ID: 32244398 [Abstract] [Full Text] [Related]
10. Silencing of Long Non-Coding RNA X Inactive Specific Transcript (Xist) Contributes to Suppression of Bronchopulmonary Dysplasia Induced by Hyperoxia in Newborn Mice via microRNA-101-3p and the transforming growth factor-beta 1 (TGF-β1)/Smad3 Axis. Yuan W, Liu X, Zeng L, Liu H, Cai B, Huang Y, Tao X, Mo L, Zhao L, Gao C. Med Sci Monit; 2020 Oct 18; 26():e922424. PubMed ID: 33070148 [Abstract] [Full Text] [Related]
11. LncRNA H19 inhibits kidney injury in sepsis rats through MAPK pathway. Wang X, Zhang Y, Han S, Yin Y, Chen C, Chen H, Gao B. Minerva Med; 2021 Jun 18; 112(3):412-413. PubMed ID: 31317684 [No Abstract] [Full Text] [Related]
12. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway. Cai Y, Dong ZY, Wang JY. Eur Rev Med Pharmacol Sci; 2018 Aug 18; 22(15):4879-4887. PubMed ID: 30070323 [Abstract] [Full Text] [Related]
13. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway. Li Y, Liu YD, Chen SL, Chen X, Ye DS, Zhou XY, Zhe J, Zhang J. Mol Hum Reprod; 2019 Jan 01; 25(1):17-29. PubMed ID: 30371869 [Abstract] [Full Text] [Related]
14. Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling. Zhou GR, Huang DP, Sun ZF, Zhang XF. Eur Rev Med Pharmacol Sci; 2020 Apr 01; 24(7):3657-3664. PubMed ID: 32329841 [Abstract] [Full Text] [Related]
15. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter. Gao LM, Xu SF, Zheng Y, Wang P, Zhang L, Shi SS, Wu T, Li Y, Zhao J, Tian Q, Yin XB, Zheng L. J Cell Mol Med; 2019 Sep 01; 23(9):6411-6428. PubMed ID: 31317666 [Abstract] [Full Text] [Related]
16. Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer. Li B, Zhou Y, Chen J, Wang T, Li Z, Fu Y, Zhai A, Bi C. FASEB J; 2021 Jan 01; 35(1):e20526. PubMed ID: 33174326 [Abstract] [Full Text] [Related]
17. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y, Wu D, Wang Y, Zhuang Z, Xia H. J Neurosurg; 2016 Jan 01; 2016(1):129-136. PubMed ID: 28306408 [Abstract] [Full Text] [Related]
18. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q, Wu H. J Cell Biochem; 2019 Mar 01; 120(3):3874-3886. PubMed ID: 30474270 [Abstract] [Full Text] [Related]
19. Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma. Ding K, Liao Y, Gong D, Zhao X, Ji W. Biochem Biophys Res Commun; 2018 Jul 12; 502(2):194-201. PubMed ID: 29800569 [Abstract] [Full Text] [Related]
20. Long non-coding RNA MALAT1 targeting STING transcription promotes bronchopulmonary dysplasia through regulation of CREB. Chen JH, Feng DD, Chen YF, Yang CX, Juan CX, Cao Q, Chen X, Liu S, Zhou GP. J Cell Mol Med; 2020 Sep 12; 24(18):10478-10492. PubMed ID: 32812343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]